COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,137 Articles (22,693 medRxiv, 8,444 bioRxiv)

Most recent first Previous |  Page 1123: Articles 11221-11230  | Next

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients
Lin, S., Kennedy, N. A., Saifuddin, A., Munoz Sandoval, D., Reynolds, C. J., Seoane, R. C., Kottoor, S. H., Pieper, F. P., Lin, K.-M., Butler, D. K., Chanchlani, N., Nice, R., Chee, D., Bewshea, C., Janjua, M., McDonald, T. J., Sebastian, S., Alexander, J. L., Constable, L., Lee, J. C., Murray, C. D., Hart, A. L., Irving, P. M., Jones, G.-R., Kok, K. B., Lamb, C. A., Lees, C. W., Altmann, D. M., Boyton, R. J., Goodhand, J. R., Powell, N., Ahmad, T., Contributors to the CLARITY IBD study
10.1101/2021.11.10.21266168 — Posted: 2021-11-11
Disparities in COVID-19 Fatalities among Working Californians
Cummings, K. J., Beckman, J., Frederick, M., Harrison, R., Nguyen, A., Snyder, R., Chan, E., Gibb, K., Rodriguez, A., Wong, J., Murray, E. L., Jain, S., Vergara, X.
10.1101/2021.11.10.21266195 — Posted: 2021-11-11 Discussion: Onsite | Offsite
The role of antiviral treatment in curbing the COVID-19 pandemic: a modeling study.
Matrajt, L., Brown, E. R., Dimitrov, D., Janes, H.
10.1101/2021.11.10.21266139 — Posted: 2021-11-11
A prototype vaccination model for endemic Covid-19 under waning immunity and imperfect vaccine take-up
Dagpunar, J. S., Wu, C.
10.1101/2021.11.06.21266002 — Posted: 2021-11-11 Discussion: Onsite
COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection
Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., Al-Delfi, Z., Abayasingam, A., Agapiou, D., Ospina Stella, A., Aggarwal, A., Gummow, J., Ferguson, C., O'Connor, S., McCartney, E. M., Lynn, D. J., Maddern, G., Gowans, E. J., Reddi, B. A., Shaw, D., Kok-Lim, C., Turville, S. G., Beard, M. R., Weiskopf, D., Sette, A., Bull, R. A., Barry, S. C., Grubor-Bauk, B.
10.1101/2021.11.08.21266035 — Posted: 2021-11-11
The β-NGF/TrkA signalling pathway is associated with the production of anti- nucleoprotein IgG in convalescent COVID-19
Usai, C., Gibbons, J. M., Pade, C., Li, W., McKnight, A., Kennedy, P. T. F., Gill, U. S.
10.1101/2021.11.11.21266223 — Posted: 2021-11-11
Mapping the human genetic architecture of COVID-19: an update
The COVID-19 Host Genetics Initiative, , Ganna, A.
10.1101/2021.11.08.21265944 — Posted: 2021-11-11
A study of the benefits of vaccine mandates and vaccine passports for SARS-CoV-2
Prosser, A., Streiner, D. L.
10.1101/2021.11.10.21266188 — Posted: 2021-11-11
Using mobile phone data to estimate dynamic population changes and improve the understanding of a pandemic: A case study in Andorra
Berke, A. A., Doorley, R., Alonso, L., Pons, M., Arroyo, V., Larson, K.
10.1101/2021.11.06.21265955 — Posted: 2021-11-11
Quantifying changes in vaccine coverage in mainstream media as a result of COVID-19 outbreak
Christensen, B., Laydon, D. J., Chelkowski, T., Jemielniak, D., Vollmer, M., Bhatt, S., Krawczyk, K.
10.1101/2021.11.07.21266018 — Posted: 2021-11-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).